Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended-interval dosing of aminoglycosides

M E Blam1, G S Hammer

  • 1Mount Sinai School of Medicine, Department of Medicine, New York, NY 10029-6574, USA.

The Mount Sinai Journal of Medicine, New York
|November 19, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives.

The American journal of gastroenterology·2001
Same author

A new endoscopic technique for the removal of gastric phytobezoars.

Gastrointestinal endoscopy·2000
Same author

Image of the month. A wind sock web deformity of the proximal duodenum.

Gastroenterology·2000
Same author

Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome.

The American journal of medicine·1992
Same author

Toward the development of consumer-based criteria for the evaluation of assistive devices.

Journal of rehabilitation research and development·1990
Same author

Cytomegalovirus-induced adrenal insufficiency and associated renal cell carcinoma in AIDS.

The Mount Sinai journal of medicine, New York·1986
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Extended-interval dosing of aminoglycosides maintains efficacy while reducing toxicity. This approach offers a safe and cost-effective strategy against bacterial resistance, enhancing antibiotic therapy.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Aminoglycoside use has decreased due to newer agents perceived as less toxic.
  • Traditional dosing regimens may not optimize aminoglycoside efficacy and safety.
  • Antibiotic resistance necessitates re-evaluation of established antimicrobial strategies.

Purpose of the Study:

  • To evaluate the efficacy and safety of extended-interval dosing for aminoglycosides.
  • To compare extended-interval dosing with traditional every-8-hour dosing.
  • To assess the role of aminoglycosides in combating bacterial resistance.

Main Methods:

  • Comprehensive literature search on aminoglycoside extended-interval dosing.
  • Analysis of bacterial resistance patterns from The Mount Sinai Hospital.

Related Experiment Videos

  • Development of a nomogram for extended-interval aminoglycoside administration.

    • Main Results:

    • Extended-interval aminoglycoside dosing is as effective as traditional every-8-hour dosing.
    • This dosing strategy may lead to reduced aminoglycoside-associated toxicities.
    • Aminoglycosides demonstrate greater susceptibility to bacterial resistance compared to newer antibiotics.

    Conclusions:

    • Extended-interval aminoglycoside dosing provides safe and effective therapy.
    • This regimen offers potential cost savings and ease of administration.
    • Increased use of aminoglycosides can be beneficial for specific bacterial infections, particularly in the context of resistance.